Healthcare provider profile · identity verified

Asma Saboor, MD

Internal Medicine · LIVONIA, MI · NPI 1841641636

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	553	155
Levothyroxine Sodium	Levothyroxine Sodium	517	133
Omeprazole	Omeprazole	391	116
Amlodipine Besylate	Amlodipine Besylate	365	106
Gabapentin	Gabapentin	299	75
Lisinopril	Lisinopril	266	73
Metoprolol Succinate	Metoprolol Succinate	263	78
Rosuvastatin Calcium	Rosuvastatin Calcium	260	89
Metformin Hcl	Metformin Hcl	233	67
Losartan Potassium	Losartan Potassium	214	68
Duloxetine Hcl	Duloxetine Hcl	202	60
Baclofen	Baclofen	182	78
Famotidine	Famotidine	182	64
Simvastatin	Simvastatin	174	47
Pantoprazole Sodium	Pantoprazole Sodium	170	54
Albuterol Sulfate Hfa	Albuterol Sulfate	166	59
Alprazolam	Alprazolam	153	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	153	38
Hydrochlorothiazide	Hydrochlorothiazide	119	37
Sertraline Hcl	Sertraline Hcl	119	32
Tramadol Hcl	Tramadol Hcl	114	23
Meloxicam	Meloxicam	109	38
Montelukast Sodium	Montelukast Sodium	107	31
Ezetimibe	Ezetimibe	102	31
Trazodone Hcl	Trazodone Hcl	101	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	100	35
Pregabalin	Pregabalin	100	21
Pravastatin Sodium	Pravastatin Sodium	98	31
Allopurinol	Allopurinol	97	29
Rybelsus	Semaglutide	97	20
Tamsulosin Hcl	Tamsulosin Hcl	97	29
Eliquis	Apixaban	92	21
Mounjaro	Tirzepatide	92	14
Metoprolol Tartrate	Metoprolol Tartrate	88	24
Citalopram Hbr	Citalopram Hydrobromide	85	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	24
Potassium Chloride	Potassium Chloride	84	28
Carvedilol	Carvedilol	82	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	21
Trulicity	Dulaglutide	79	15
Alendronate Sodium	Alendronate Sodium	74	24
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	72	18
Azelastine Hcl	Azelastine Hcl	72	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	16
Fluticasone Propionate	Fluticasone Propionate	68	31
Furosemide	Furosemide	68	26
Buspirone Hcl	Buspirone Hcl	62	23
Atenolol	Atenolol	60	19
Tizanidine Hcl	Tizanidine Hcl	60	19
Clonazepam	Clonazepam	59	suppressed
Clopidogrel	Clopidogrel Bisulfate	58	18
Estradiol	Estradiol	58	22
Fluoxetine Hcl	Fluoxetine Hcl	58	14
Spironolactone	Spironolactone	56	14
Hydroxyzine Hcl	Hydroxyzine Hcl	53	22
Ventolin Hfa	Albuterol Sulfate	51	suppressed
Warfarin Sodium	Warfarin Sodium	50	15
Amitriptyline Hcl	Amitriptyline Hcl	48	13
Bupropion Xl	Bupropion Hcl	46	14
Fenofibrate	Fenofibrate Nanocrystallized	46	suppressed
Metformin Hcl Er	Metformin Hcl	45	16
Paroxetine Hcl	Paroxetine Hcl	45	11
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	44	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	39
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	42	suppressed
Glimepiride	Glimepiride	41	suppressed
Ibuprofen	Ibuprofen	41	17
Prednisone	Prednisone	41	27
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	11
Escitalopram Oxalate	Escitalopram Oxalate	40	14
Ozempic	Semaglutide	40	suppressed
Lovastatin	Lovastatin	38	suppressed
Xarelto	Rivaroxaban	38	12
Glipizide Er	Glipizide	37	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	23
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Acetaminophen-Codeine	Acetaminophen With Codeine	34	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Enalapril Maleate	Enalapril Maleate	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	12
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Synthroid	Levothyroxine Sodium	30	11
Farxiga	Dapagliflozin Propanediol	29	suppressed
Irbesartan	Irbesartan	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	24
Methylprednisolone	Methylprednisolone	26	21
Novolog Flexpen	Insulin Aspart	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ramipril	Ramipril	26	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Finasteride	Finasteride	24	suppressed
Glipizide	Glipizide	24	suppressed
Cephalexin	Cephalexin	23	16
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Repatha Sureclick	Evolocumab	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	21	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Ciclopirox	Ciclopirox	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Nystatin	Nystatin	18	13
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Ondansetron Odt	Ondansetron	16	11
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Invokana	Canagliflozin	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Topiramate	Topiramate	15	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pen Needle	Pen Needle, Diabetic	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Azithromycin	Azithromycin	13	12
Celecoxib	Celecoxib	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Epinephrine	Epinephrine	13	11
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Fluconazole	Fluconazole	12	11
Januvia	Sitagliptin Phosphate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Colchicine	Colchicine	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Repatha Syringe	Evolocumab	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error